MicroBase Technology Corp.

MicroBase Technology Corp.

TTPEX:3184
13.40
TWD
+0.35
(+2.68%)
1.07BMarket Cap
MicroBase Technology Corp.
TPEX:3184
(Taipei Exchange)

Recent

price

13.40

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
TWD
6.09
10.09
6.9
2.4
2.57
2.29
2.78
6.4
5.17
4.09
3.37
2.89
3.09
3.4
3.36
- -
Revenue per Share
-2
2.03
0.48
-4.27
-2.02
-3.35
-2.42
-0.35
-0.96
-1.21
-0.59
0.1
0.6
1.1
0.48
- -
Basic EPS, GAAP
-5.53
2.01
3.77
-1.56
-1.98
-2.49
-2.71
-1.43
-2.28
-1.45
0.02
0.34
-0.59
1.04
0.36
- -
Free Cash Flow per Basic Share
- -
- -
0.63
0.13
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
11.44
13.81
14.73
10.4
11.38
8.11
5.81
6.35
5.38
8.71
8.11
8.23
8.84
9.95
10.44
10.72
Book Value per Share
11.44
13.81
14.72
10.38
11.3
8
5.71
6.3
5.34
8.68
8.09
8.21
8.82
9.94
10.44
10.71
Tangible Book Value per Share
30
35
38
38
41
48
49
51
51
61
63
63
63
63
63
63
Basic Weighted Avg Shares
181
357
261
91
106
111
136
324
265
250
213
182
195
215
212
- -
Sales/Revenue/Turnover
-35.44
22.09
8.34
-129.79
-100.45
-125.66
-87.58
-3.07
-16
-30.21
-14.43
-7.51
11.06
24.77
21.67
- -
Operating Margin (%)
52
60
58
53
42
41
41
38
30
26
22
15
14
13
13
- -
Depreciation Expense
-60
72
18
-162
-83
-162
-118
-18
-49
-74
-37
6
38
69
30
- -
Net Income, GAAP
- -
2.91
19.94
- -
- -
- -
- -
- -
- -
- -
- -
37.45
- -
1.25
- -
- -
Effective Tax Rate (%)
-32.92
20.14
6.9
-177.63
-78.8
-146.16
-87.16
-5.53
-18.47
-29.6
-17.55
3.49
19.57
32.33
14.24
- -
Profit Margin (%)
72
188
174
82
306
199
120
130
28
256
231
201
165
244
269
290
Working Capital
212
168
80
68
64
58
82
77
68
54
44
24
1
1
1
- -
LT Debt
369
501
558
394
547
405
291
333
280
549
512
519
557
628
659
673
Total Equity
- -
11.32
2.5
- -
- -
- -
- -
- -
- -
- -
- -
-1.41
- -
8.57
- -
- -
Return on Invested Capital (%)
- -
11.36
2.94
- -
- -
- -
- -
- -
- -
- -
- -
1.22
- -
11.36
- -
- -
Return on Capital (%)
- -
16.52
3.4
-34
-17.67
-34.3
-34.75
-5.86
-16.28
-17.93
-7.04
1.23
7.08
11.72
4.69
- -
Return on Common Equity (%)

Capital Structure

TWD

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
ST Debt
19
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
1
1
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
63
63
63
Market Capitalization
819
588
1,070

Working Capital

TWD

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
Total Current Assets
307
290
339
Cash, Cash Equivalents & STI
218
221
256
Accounts Receivable, Net
31
21
31
Inventories
36
30
32
Total Current Liabilities
49
21
49
Payables & Accruals
- -
- -
- -
ST Debt
19
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

TWD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
6%
3.91%
4.92%
Free Cash Flow
110.16%
210.31%
-65.71%
Net Income, GAAP
56.58%
71.78%
-56.59%
Sales/Revenue/Turnover
12.89%
-2.69%
-1.43%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

TWD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
215
2025
- -
- -
212
2026
- -
- -
- -

Semi-annual Earnings Per Share

TWD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
1.1
2025
- -
- -
0.48
2026
- -
- -
- -

Semi-annual Dividends Per Share

TWD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -
Business
MicroBase Technology Corp., founded in Taoyuan City, Taiwan in 1997, delivers advanced drug administration solutions to patients and medical professionals globally. The company's core strength lies in developing non-silicon-based micro-electromechanical systems (MEMS) through proprietary LIGA technology, enabling the creation of miniaturized devices and micron-scale components. They stand as a prominent Asian entity with integrated capabilities in laser material processing and high-volume production. Among its offerings, MicroBase features the Pocket Air line, which includes portable mesh nebulizers for treating a variety of respiratory conditions, such as the GOCare® and LoyalCare™ models. These devices utilize vibrating mesh technology to provide efficient aerosol drug delivery. Additionally, the company develops PharMatrix, a range of microneedle products designed for at-home cosmetic applications, utilizing a non-silicon-based electroplating molding process. MicroBase also produces nozzle plates for electronic consumer products. The firm has achieved significant market presence, with over one million Pocket Air units sold worldwide, and continues to expand its global reach with recent medical device approvals in markets like Malaysia. MicroBase holds more than 450 patents covering its innovative technologies and products.